This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Tricida Management

Management criteria checks 3/4

Key information

Gerrit Klaerner

Chief executive officer

US$4.7m

Total compensation

CEO salary percentage12.8%
CEO tenure9.7yrs
CEO ownership0.7%
Management average tenure3.9yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Gerrit Klaerner's remuneration changed compared to Tricida's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a

-US$134m

Jun 30 2022n/an/a

-US$148m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$5mUS$600k

-US$177m

Sep 30 2021n/an/a

-US$181m

Jun 30 2021n/an/a

-US$219m

Mar 31 2021n/an/a

-US$244m

Dec 31 2020US$9mUS$598k

-US$265m

Sep 30 2020n/an/a

-US$268m

Jun 30 2020n/an/a

-US$235m

Mar 31 2020n/an/a

-US$213m

Dec 31 2019US$10mUS$584k

-US$177m

Sep 30 2019n/an/a

-US$146m

Jun 30 2019n/an/a

-US$131m

Mar 31 2019n/an/a

-US$120m

Dec 31 2018US$1mUS$503k

-US$103m

Sep 30 2018n/an/a

-US$96m

Jun 30 2018n/an/a

-US$77m

Mar 31 2018n/an/a

-US$60m

Dec 31 2017US$821kUS$425k

-US$41m

Compensation vs Market: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the German market ($USD425.34K).

Compensation vs Earnings: Gerrit's compensation has been consistent with company performance over the past year.


CEO

Gerrit Klaerner (50 yo)

9.7yrs

Tenure

US$4,676,490

Compensation

Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...


Leadership Team

NamePositionTenureCompensationOwnership
Gerrit Klaerner
Founder9.7yrsUS$4.68m0.68%
$ 2.5k
Geoffrey Parker
COO, CFO & Executive VP6yrsUS$2.51m0.72%
$ 2.7k
Robert McKague
Executive VP3.1yrsUS$2.43m0.031%
$ 112.3
Dawn Parsell
Executive Vice President of Clinical Development4.7yrsUS$2.77m0.0060%
$ 22.0
Annie Yoshiyama
VP of Finance & Chief Accounting Officer2.3yrsno datano data
Jackie Cossmon
Vice President of Investor Relations & Communicationsno datano datano data
Edward Hejlek
Executive Vice President of Intellectual Property3.1yrsUS$2.10mno data

3.9yrs

Average Tenure

57yo

Average Age

Experienced Management: 1T7's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gerrit Klaerner
Founder9.8yrsUS$4.68m0.68%
$ 2.5k
Kathryn Falberg
Independent Non-Employee Director4.9yrsUS$329.00k0.074%
$ 271.2
Klaus Veitinger
Independent Chairman of the Board9.2yrsUS$379.00k0.20%
$ 723.3
David Hirsch
Independent Non-Employee Director6.8yrsUS$326.50k0.019%
$ 70.9
Robert Alpern
Member of Scientific & Clinical Advisory Board and Independent Non-Employee Director9.5yrsUS$314.00k0%
$ 0
John Fordtran
Member of Scientific & Clinical Advisory Boardno datano datano data
David Bushinsky
Member of Scientific & Clinical Advisory Boardno datano datano data
Craig Hawker
Member of Scientific & Clinical Advisory Boardno datano datano data
Sandra Coufal
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.8yrsUS$316.50k0.15%
$ 554.7
Navdeep Tangri
Member of Scientific & Clinical Advisory Boardno datano datano data
Thomas Hostetter
Member of Scientific & Clinical Advisory Boardno datano datano data
Bertram Pitt
Member of Scientific and Clinical Advisory Boardno datano datano data

9.3yrs

Average Tenure

59yo

Average Age

Experienced Board: 1T7's board of directors are considered experienced (9.3 years average tenure).